Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
See Latest ArticlesProton pump inhibitors and the risk of colorectal cancer
The American Journal of Gastroenterology, 04/09/08
van Soest EM et al. - In a study to investigate the association between the use of proton pump inhibitors (PPI) and the risk of colorectal cancer (CRC), it seems that no association was found between PPI use and the risk of CRC
Methods- Cases with CRC were matched with up to 20 controls on age, gender, calendar time, and duration of follow-up prior to diagnosis
- Cumulative exposure to PPIs was assessed in the 5 yr prior to diagnosis with a 1-yr lag time analysis
- Adjusted odds ratios (OR) were calculated with 95% confidence intervals using multivariate, conditional logistic regression analysis
- Within the source population of 457,024 persons, 595 CRC cases were identified
- The odds of CRC were not increased among pts ever using PPIs compared with pts who never used PPIs
- Use of PPIs for >365 days was not associated with a greater risk of CRC compared with nonusers
- The odds of CRC in neither the right nor the left hemicolon were significantly increased in pts using PPIs
Related Articles
Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II
Cancer Epidemiology, Biomarkers & Prevention, 10/28/09
Relevance Score: 92%
Association of IGF1 and IGFBP3 polymorphisms with colorectal polyps and colorectal cancer risk
Cancer Causes and Control, 10/02/09
Relevance Score: 92%
trans-Fatty acid consumption and its association with distal colorectal cancer in the North Carolina Colon Cancer Study II
Cancer Causes and Control, 10/28/09
Relevance Score: 91%
In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer
Journal of Clinical Oncology, 10/30/09
Relevance Score: 90%
Association of selected polymorphisms of CCND1, p21, and caspase8 With colorectal cancer risk
Molecular Carcinogenesis, 10/05/09
Relevance Score: 90%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effect of targeting normal fasting glucose levels with basal insulin glargine on glycaemic variability and risk of hypoglycaemia: a randomized, controlled study in patients with early Type 2 diabetes
Diabetic Medicine, 02/09/10
Pregabalin in fibromyalgia: Meta-analysis of efficacy and safety from company clinical trial reports
Rheumatology, 02/09/10
Capsaicin jelly against migraine pain
International Journal of Clinical Practice, 02/09/10
Today in Gastroenterology...keeping you current
Receive free subspecialty "5-minute updates" via email
Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study
The Lancet - Early Online Publication, 02/09/10
Mesalazine in inflammatory bowel disease: A trendy topic once again
Canadian Journal of Gastroenterology, 02/09/10
Failure of automated telephone outreach with speech recognition to improve colorectal cancer screening
Archives of Internal Medicine, 02/09/10
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Drug Approval Summary: Bevacizumab plus Interferon for Advanced Renal Cell Carcinoma
The Oncologist, 02/09/10
Cancer epidemiology in France in 2010, comparison with the USA
Bulletin du Cancer, 02/09/10
Rectal cancer and adjuvant chemotherapy: which conclusions
Bulletin du Cancer, 02/09/10
Article Search
Sponsor
Sponsor